SEC Company Response from HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853) (HSDT) — Jan 4, 2017
HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT, HSDTW) (CIK 0001610853)
Date: Jan. 4, 2017 · CIK: 0001610853 · Accession: 0001193125-17-002113
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-215286
Letter
January 4, 2017
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn: Tim Buchmiller
Amanda Ravitz
Re: Helius Medical Technologies, Inc.
Registration Statement on Form S-3
File No. 333-215286
Acceleration Request
Requested Date:
Friday, January 6, 2017
Requested Time:
4:30 P.M. Eastern Standard Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-215286) (the “Registration Statement”) to become effective on Friday, January 6, 2017, at 4:30 p.m. Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant, at (703) 456-8034, or in his absence, William DuVal at (703) 456-8663.
[Signature page follows]
Very truly yours,
Helius Medical Technologies, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
January 4, 2017
Via EDGAR
U.S. Securities and Exchange
Commission
Division of Corporation Finance
100 F Street,
N.E.
Mail Stop 4546
Washington, D.C. 20549
Attn:
Tim Buchmiller
Amanda Ravitz
Re:
Helius Medical Technologies, Inc.
Registration Statement on Form S-3
File No. 333-215286
Acceleration Request
Requested Date:
Friday, January 6, 2017
Requested Time:
4:30 P.M. Eastern Standard Time
Ladies and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take
appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-215286) (the “Registration Statement”) to become effective on Friday, January 6, 2017, at 4:30 p.m. Eastern
Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).
Once the Registration Statement has been declared effective, please orally confirm that event with Darren DeStefano of Cooley LLP, counsel to the Registrant,
at (703) 456-8034, or in his absence, William DuVal at (703) 456-8663.
[Signature page
follows]
Very truly yours,
Helius Medical Technologies, Inc.
By:
/s/ Joyce LaViscount
Joyce LaViscount
Chief Financial Officer
cc:
Philippe Deschamps, Helius Medical Technologies, Inc.
Darren DeStefano, Cooley LLP